Posted By: NITRC ADMIN - Nov 21, 2017 Tool/Resource: Journals
The role of fMRI in drug development. Drug Discov Today. 2017 Nov 15;: Authors: Carmichael O, Schwarz AJ, Chatham CH, Scott D, Turner JA, Upadhyay J, Coimbra A, Goodman JA, Baumgartner R, English BA, Apolzan JW, Shankapal P, Hawkins KR Abstract Functional magnetic resonance imaging (fMRI) has been known for over a decade to have the potential to greatly enhance the process of developing novel therapeutic drugs for prevalent health conditions. However, the use of fMRI in drug development continues to be relatively limited because of a variety of technical, biological, and strategic barriers that continue to limit progress. Here, we briefly review the roles that fMRI can have in the drug development process and the requirements it must meet to be useful in this setting. We then provide an update on our current understanding of the strengths and limitations of fMRI as a tool for drug developers, and recommended activities to enhance its utility. PMID: 29154758 [PubMed - as supplied by publisher]
Link to Original Article |
You can link this page to your Slack channel. When you do this, every new posting on this NITRC page will trigger a short message on your Slack channel linking to the update. If you have the RSS App installed in your Slack workspace, you can paste this slash command directly into your channel:
/feed https://www.nitrc.org/export/rss20_forum.php?forum_id=8014
Full instructions for installing and using the RSS app with Slack feed to Slack can be found in the Slack Help Center.
This news item currently has no comments.